TABLE 3.
Characteristics of participants who consumed a low, medium, or high dose of intrinsically labeled casein1
T1 (n = 120) | T2 (n = 120) | T3 (n = 119) | |
---|---|---|---|
Dose | |||
g | 20 ± 1a | 21 ± 2a | 33 ± 7b |
g/kg BM | 0.24 ± 0.01a | 0.28 ± 0.02b | 0.44 ± 0.07c |
g/kg LBM | 0.31 ± 0.02a | 0.36 ± 0.04b | 0.55 ± 0.11c |
Age, y | 60 ± 21a | 56 ± 24a | 46 ± 25b |
Men/women, n/n | 120/0 | 120/0 | 119/0 |
Height, m | 1.79 ± 0.07a | 1.76 ± 0.07b | 1.78 ± 0.07a,b |
BM, kg | 84.1 ± 5.4a | 73.3 ± 6.7b | 73.4 ± 9.4b |
BMI, kg/m2 | 26.5 ± 2.1a | 23.7 ± 2.3b | 23.3 ± 2.8b |
Fat, % | 21.1 ± 4.0a | 18.5 ± 4.9b | 17.0 ± 5.0b |
ALM, kg | 27.6 ± 2.8a | 25.2 ± 2.5b | 27.0 ± 3.9a |
LBM, kg | 64.5 ± 4.8a | 57.9 ± 4.2b | 58.4 ± 7.0b |
HbA1c, % | 5.9 ± 0.9a | 5.6 ± 0.4b | 5.6 ± 0.4b |
Plasma glucose, mmol/L | |||
Fasting | 6.3 ± 1.9a | 5.7 ± 0.8b | 5.7 ± 0.7b |
2 h post–75-g oral-glucose | 7.8 ± 4.7a | 6.1 ± 2.4b | 6.0 ± 1.5b |
Values are means ± SDs. Labeled means (in a row) without a common letter differ, P < 0.05. Protein dose ranged from 0.20 to 0.25 g/kg BM for T1, 0.26 to 0.33 g/kg BM for T2, and 0.34 to 0.64 g/kg BM for T3. ALM, appendicular lean mass; BM, body mass; HbA1c, glycated hemoglobin; LBM, lean body mass; T, tertile.